Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions

Zachary R. Chalmers, Michael C. Burns, Ericka M. Ebot, Garrett M. Frampton, Jeffrey S. Ross, Maha H.A. Hussain*, Sarki A. Abdulkadir

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2–ERG fusions'. Together they form a unique fingerprint.

Medicine & Life Sciences